Equities

Protagonist Therapeutics Inc

PTGX:NMQ

Protagonist Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)46.23
  • Today's Change-1.38 / -2.90%
  • Shares traded682.76k
  • 1 Year change+189.48%
  • Beta2.1923
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Protagonist Therapeutics Inc (PTGX:NMQ) closed at 46.23, -5.44% below its 52-week high of 48.89, set on Oct 28, 2024.
52-week range
Today
14.78Nov 10 202348.89Oct 28 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open48.86
High48.86
Low45.23
Bid35.20
Offer73.96
Previous close47.61
Average volume523.38k
Shares outstanding58.90m
Free float56.88m
P/E (TTM)17.53
Market cap2.72bn USD
EPS (TTM)2.64
USD
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼

Events & Activity

  • PTGX:NMQ reported earnings of -0.540 for the period of the year 2024Q3.
  • PTGX:NMQ price falls below 50-day moving average to 45.28 at 10:25 GMT
  • PTGX:NMQ price moved over +4.75% to 48.10
  • PTGX:NMQ trading volume exceeds daily average by +15.01%
  • PTGX:NMQ price falls below 15-day moving average to 46.95 at 09:35 GMT
  • PTGX:NMQ price falls below 15-day moving average to 46.95 at 14:20 GMT
  • PTGX:NMQ price rises above 15-day moving average to 48.10 at 09:30 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.